Learning Objective 1: List three factors that are protective for ovarian cancer and three factors that place a woman at risk for developing ovarian cancer.
Learning Objective 2: Describe the validity and reliability of the newly developed self-report instrument
Objectives:
- Develop a self-report scale to assess the cumulative effect of multiple causative and protective factors leading to ovarian cancer
- Establish content and construct validity of the instrument
- Establish reliability of the instrument
Method/Procedure for tool development: Due to non-availability of a relevant, multifaceted and comprehensive measure for examining multiple causative and protective factors leading to ovarian cancer, a self-report instrument is being developed based on a comprehensive literature review. Content and construct validity will be determined by factor analysis and expert review before being pilot tested. Statistical properties of each item will be determined and the items revised or deleted based on the empirical data. Reliability will be determined by retesting.
Results: Risks include: genetic factors; family or personal history of ovarian, breast, or colon cancer; aging; hormonal factors including early puberty, late menopause, nulliparity, infertility, and estrogen replacement therapy; obesity and dietary patterns; environmental/occupational exposure to pesticides, chemicals, asbestos, diesel fumes, and talcum powder; lifestyle factors of inactivity, alcohol use, smoking, and sexual orientation. Protective factors identified include use of contraception, breastfeeding, pregnancy, diet and exercise, certain medications, and specific menstrual cycle characteristics.
Discussion & Conclusions: Instrument development will provide a means to investigate the multifaceted nature of the risks and protective factors related to ovarian cancer. Until a physiologically-based population screening test is developed, healthcare providers need more information about the combination of factors predisposing women to this deadly disease.